{"transactions":[{"id":4627840,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36687,"kind":"person","name":"Mancini Anthony","position":1,"cik":"0002124509","reported_name":"Mancini Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-09-28T22:00:04.000Z","date":"2026-09-25","kind":"exercise","planned":true,"acquired":false,"shares":3121,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Anthony Mancini on June 11, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Twenty-five percent of the total shares subject to the option will vest on the first year anniversary measured from April 1, 2025 (the \"Vesting Commencement Date\") and one forty-eighth (1/48th) of the shares subject to the option will vest on each monthly anniversary of the Vesting Commencement Date thereafter, so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date."}],"balance_after":93625,"derivative":{"exercise_price":33.62,"expiration_date":"2035-03-31","underlying":"Common Stock","underlying_shares":3121},"source":{"system":"sec-edgar","filing":"0002124509-26-000012","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2124509/000212450926000012/ownership.xml","form_type":"4"}},{"id":4627839,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36687,"kind":"person","name":"Mancini Anthony","position":1,"cik":"0002124509","reported_name":"Mancini Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-09-28T22:00:04.000Z","date":"2026-09-25","kind":"sale","planned":true,"acquired":false,"shares":3121,"price":200.54,"value":625885.34,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Anthony Mancini on June 11, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 39,575 restricted stock units."}],"balance_after":39765,"source":{"system":"sec-edgar","filing":"0002124509-26-000012","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2124509/000212450926000012/ownership.xml","form_type":"4"}},{"id":4627838,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36687,"kind":"person","name":"Mancini Anthony","position":1,"cik":"0002124509","reported_name":"Mancini Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-09-28T22:00:04.000Z","date":"2026-09-25","kind":"exercise","planned":true,"acquired":true,"shares":3121,"price":33.62,"value":104928.02,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Anthony Mancini on June 11, 2026."}],"balance_after":42886,"source":{"system":"sec-edgar","filing":"0002124509-26-000012","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2124509/000212450926000012/ownership.xml","form_type":"4"}},{"id":4627837,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36687,"kind":"person","name":"Mancini Anthony","position":1,"cik":"0002124509","reported_name":"Mancini Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-09-28T22:00:04.000Z","date":"2026-09-24","kind":"sale","planned":true,"acquired":false,"shares":587,"price":200,"value":117400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Anthony Mancini on June 11, 2026."}],"balance_after":39765,"source":{"system":"sec-edgar","filing":"0002124509-26-000012","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2124509/000212450926000012/ownership.xml","form_type":"4"}},{"id":4624917,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36687,"kind":"person","name":"Mancini Anthony","position":1,"cik":"0002124509","reported_name":"Mancini Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-09-22T22:00:03.000Z","date":"2026-09-18","kind":"sale","planned":true,"acquired":false,"shares":1764,"price":196.94,"value":347402.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Anthony Mancini on June 11, 2026."}],"balance_after":40352,"source":{"system":"sec-edgar","filing":"0002124509-26-000010","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2124509/000212450926000010/ownership.xml","form_type":"4"}},{"id":4624336,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36687,"kind":"person","name":"Mancini Anthony","position":1,"cik":"0002124509","reported_name":"Mancini Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-09-18T22:05:04.000Z","date":"2026-09-16","kind":"sale","planned":true,"acquired":false,"shares":1747,"price":199.3032,"value":348182.6904,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on June 15, 2026 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 39,575 restricted stock units."}],"balance_after":42116,"source":{"system":"sec-edgar","filing":"0002124509-26-000008","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000212450926000008/ownership.xml","form_type":"4"}},{"id":4624335,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36687,"kind":"person","name":"Mancini Anthony","position":1,"cik":"0002124509","reported_name":"Mancini Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-09-18T22:05:04.000Z","date":"2026-09-16","kind":"sale","planned":true,"acquired":false,"shares":27,"price":195.0521,"value":5266.4067,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on June 15, 2026 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades at prices ranging from $195.03 to $195.07, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":43863,"source":{"system":"sec-edgar","filing":"0002124509-26-000008","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000212450926000008/ownership.xml","form_type":"4"}},{"id":4617427,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36687,"kind":"person","name":"Mancini Anthony","position":1,"cik":"0002124509","reported_name":"Mancini Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-09-14T22:03:59.000Z","date":"2026-09-10","kind":"exercise","planned":true,"acquired":false,"shares":9363,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Anthony Mancini on June 11, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Twenty-five percent of the total shares subject to the option will vest on the first year anniversary measured from April 1, 2025 (the \"Vesting Commencement Date\") and one forty-eighth (1/48th) of the shares subject to the option will vest on each monthly anniversary of the Vesting Commencement Date thereafter, so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date."}],"balance_after":96746,"derivative":{"exercise_price":33.62,"expiration_date":"2035-03-31","underlying":"Common Stock","underlying_shares":9363},"source":{"system":"sec-edgar","filing":"0002124509-26-000004","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/2124509/000212450926000004/ownership.xml","form_type":"4"}},{"id":4617426,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36687,"kind":"person","name":"Mancini Anthony","position":1,"cik":"0002124509","reported_name":"Mancini Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-09-14T22:03:59.000Z","date":"2026-09-10","kind":"sale","planned":true,"acquired":false,"shares":300,"price":207.1733,"value":62151.99,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Anthony Mancini on June 11, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The transaction was executed in multiple trades at prices ranging from $207.12 to $207.28, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Includes 43,700 restricted stock units."}],"balance_after":43890,"source":{"system":"sec-edgar","filing":"0002124509-26-000004","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/2124509/000212450926000004/ownership.xml","form_type":"4"}},{"id":4617425,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36687,"kind":"person","name":"Mancini Anthony","position":1,"cik":"0002124509","reported_name":"Mancini Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-09-14T22:03:59.000Z","date":"2026-09-10","kind":"sale","planned":true,"acquired":false,"shares":1179,"price":206.0995,"value":242991.3105,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Anthony Mancini on June 11, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The transaction was executed in multiple trades at prices ranging from $205.85 to $206.70, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":44190,"source":{"system":"sec-edgar","filing":"0002124509-26-000004","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/2124509/000212450926000004/ownership.xml","form_type":"4"}},{"id":4617424,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36687,"kind":"person","name":"Mancini Anthony","position":1,"cik":"0002124509","reported_name":"Mancini Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-09-14T22:03:59.000Z","date":"2026-09-10","kind":"sale","planned":true,"acquired":false,"shares":2420,"price":205.0513,"value":496224.146,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Anthony Mancini on June 11, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The transaction was executed in multiple trades at prices ranging from $204.64 to $205.55, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":45369,"source":{"system":"sec-edgar","filing":"0002124509-26-000004","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2124509/000212450926000004/ownership.xml","form_type":"4"}},{"id":4617423,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36687,"kind":"person","name":"Mancini Anthony","position":1,"cik":"0002124509","reported_name":"Mancini Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-09-14T22:03:59.000Z","date":"2026-09-10","kind":"sale","planned":true,"acquired":false,"shares":5530,"price":204.1357,"value":1128870.421,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Anthony Mancini on June 11, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The transaction was executed in multiple trades at prices ranging from $203.64 to $204.63, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":47789,"source":{"system":"sec-edgar","filing":"0002124509-26-000004","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2124509/000212450926000004/ownership.xml","form_type":"4"}},{"id":4617422,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36687,"kind":"person","name":"Mancini Anthony","position":1,"cik":"0002124509","reported_name":"Mancini Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-09-14T22:03:59.000Z","date":"2026-09-10","kind":"sale","planned":true,"acquired":false,"shares":6019,"price":203.2844,"value":1223568.8036,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Anthony Mancini on June 11, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades at prices ranging from $202.64 to $203.63, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":53319,"source":{"system":"sec-edgar","filing":"0002124509-26-000004","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2124509/000212450926000004/ownership.xml","form_type":"4"}},{"id":4617421,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36687,"kind":"person","name":"Mancini Anthony","position":1,"cik":"0002124509","reported_name":"Mancini Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-09-14T22:03:59.000Z","date":"2026-09-10","kind":"exercise","planned":true,"acquired":true,"shares":9363,"price":33.62,"value":314784.06,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Anthony Mancini on June 11, 2026."}],"balance_after":59338,"source":{"system":"sec-edgar","filing":"0002124509-26-000004","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2124509/000212450926000004/ownership.xml","form_type":"4"}},{"id":731653,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36687,"kind":"person","name":"Mancini Anthony","position":1,"cik":"0002124509","reported_name":"Mancini Anthony","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-06-18T20:11:23.000Z","date":"2026-06-16","kind":"sale","planned":false,"acquired":false,"shares":4615,"price":156.1192,"value":720490.108,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to an automatic sell-to-cover, the shares were sold following the vesting of the restricted stock units solely to cover applicable withholding taxes."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $156.1105 to $156.8250. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 43,700 Restricted Stock Units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 190 shares acquired under the Issuer's Employee Stock Purchase Plan on May 31, 2026."}],"balance_after":49975,"source":{"system":"sec-edgar","filing":"0001610717-26-000247","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000161071726000247/form4.xml","form_type":"4"}},{"id":759824,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36687,"kind":"person","name":"Mancini Anthony","position":1,"cik":"0002124509","reported_name":"Mancini Anthony","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-28T20:10:48.000Z","date":"2026-05-26","kind":"exercise","planned":true,"acquired":false,"shares":3121,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Anthony Mancini on December 24, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Twenty-five percent of the total shares subject to the option will vest on the first year anniversary measured from April 1, 2025 (the \"Vesting Commencement Date\") and one forty-eighth (1/48th) of the shares subject to the option will vest on each monthly anniversary of the Vesting Commencement Date thereafter, so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date."}],"balance_after":106109,"derivative":{"exercise_price":33.62,"expiration_date":"2035-03-31","underlying":"Common Stock","underlying_shares":3121},"source":{"system":"sec-edgar","filing":"0001610717-26-000166","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000161071726000166/form4.xml","form_type":"4"}},{"id":759823,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36687,"kind":"person","name":"Mancini Anthony","position":1,"cik":"0002124509","reported_name":"Mancini Anthony","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-05-28T20:10:48.000Z","date":"2026-05-26","kind":"sale","planned":true,"acquired":false,"shares":421,"price":154.8157,"value":65177.4097,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Anthony Mancini on December 24, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $154.70 to $154.95. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 54,400 Restricted Stock Units."}],"balance_after":54400,"source":{"system":"sec-edgar","filing":"0001610717-26-000166","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000161071726000166/form4.xml","form_type":"4"}},{"id":759822,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36687,"kind":"person","name":"Mancini Anthony","position":1,"cik":"0002124509","reported_name":"Mancini Anthony","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-05-28T20:10:48.000Z","date":"2026-05-26","kind":"sale","planned":true,"acquired":false,"shares":2000,"price":154.0609,"value":308121.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Anthony Mancini on December 24, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $153.65 to $154.51. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 54,400 Restricted Stock Units."}],"balance_after":54821,"source":{"system":"sec-edgar","filing":"0001610717-26-000166","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000161071726000166/form4.xml","form_type":"4"}},{"id":759821,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36687,"kind":"person","name":"Mancini Anthony","position":1,"cik":"0002124509","reported_name":"Mancini Anthony","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-05-28T20:10:48.000Z","date":"2026-05-26","kind":"sale","planned":true,"acquired":false,"shares":700,"price":153.3023,"value":107311.61,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Anthony Mancini on December 24, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $152.64 to $153.48. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 54,400 Restricted Stock Units."}],"balance_after":56821,"source":{"system":"sec-edgar","filing":"0001610717-26-000166","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000161071726000166/form4.xml","form_type":"4"}},{"id":759820,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36687,"kind":"person","name":"Mancini Anthony","position":1,"cik":"0002124509","reported_name":"Mancini Anthony","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-05-28T20:10:48.000Z","date":"2026-05-26","kind":"exercise","planned":true,"acquired":true,"shares":3121,"price":33.62,"value":104928.02,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Anthony Mancini on December 24, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 54,400 Restricted Stock Units."}],"balance_after":57521,"source":{"system":"sec-edgar","filing":"0001610717-26-000166","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000161071726000166/form4.xml","form_type":"4"}},{"id":797822,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36687,"kind":"person","name":"Mancini Anthony","position":1,"cik":"0002124509","reported_name":"Mancini Anthony","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-29T21:50:57.000Z","date":"2026-04-27","kind":"exercise","planned":true,"acquired":false,"shares":3120,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Anthony Mancini on December 24, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Twenty-five percent of the total shares subject to the option will vest on the first year anniversary measured from April 1, 2025 (the \"Vesting Commencement Date\") and one forty-eighth (1/48th) of the shares subject to the option will vest on each monthly anniversary of the Vesting Commencement Date thereafter, so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date."}],"balance_after":109230,"derivative":{"exercise_price":33.62,"expiration_date":"2035-03-31","underlying":"Common Stock","underlying_shares":3120},"source":{"system":"sec-edgar","filing":"0001610717-26-000158","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000161071726000158/form4.xml","form_type":"4"}},{"id":797821,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36687,"kind":"person","name":"Mancini Anthony","position":1,"cik":"0002124509","reported_name":"Mancini Anthony","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-04-29T21:50:57.000Z","date":"2026-04-27","kind":"sale","planned":true,"acquired":false,"shares":400,"price":134.335,"value":53734.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Anthony Mancini on December 24, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $134.04 to $134.60. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 54,400 Restricted Stock Units."}],"balance_after":54400,"source":{"system":"sec-edgar","filing":"0001610717-26-000158","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000161071726000158/form4.xml","form_type":"4"}},{"id":797820,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36687,"kind":"person","name":"Mancini Anthony","position":1,"cik":"0002124509","reported_name":"Mancini Anthony","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-04-29T21:50:57.000Z","date":"2026-04-27","kind":"sale","planned":true,"acquired":false,"shares":1049,"price":132.8768,"value":139387.7632,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Anthony Mancini on December 24, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $132.37 to $133.35. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 54,400 Restricted Stock Units."}],"balance_after":54800,"source":{"system":"sec-edgar","filing":"0001610717-26-000158","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000161071726000158/form4.xml","form_type":"4"}},{"id":797819,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36687,"kind":"person","name":"Mancini Anthony","position":1,"cik":"0002124509","reported_name":"Mancini Anthony","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-04-29T21:50:57.000Z","date":"2026-04-27","kind":"sale","planned":true,"acquired":false,"shares":1671,"price":131.6619,"value":220007.0349,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Anthony Mancini on December 24, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $131.08 to $132.06. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 54,400 Restricted Stock Units."}],"balance_after":55849,"source":{"system":"sec-edgar","filing":"0001610717-26-000158","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000161071726000158/form4.xml","form_type":"4"}},{"id":797818,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36687,"kind":"person","name":"Mancini Anthony","position":1,"cik":"0002124509","reported_name":"Mancini Anthony","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-04-29T21:50:57.000Z","date":"2026-04-27","kind":"exercise","planned":true,"acquired":true,"shares":3120,"price":33.62,"value":104894.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Anthony Mancini on December 24, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 54,400 Restricted Stock Units."}],"balance_after":57520,"source":{"system":"sec-edgar","filing":"0001610717-26-000158","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000161071726000158/form4.xml","form_type":"4"}},{"id":827151,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36687,"kind":"person","name":"Mancini Anthony","position":1,"cik":"0002124509","reported_name":"Mancini Anthony","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-27T00:04:12.000Z","date":"2026-03-25","kind":"exercise","planned":true,"acquired":false,"shares":37450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Anthony Mancini on December 24, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Twenty-five percent of the total shares subject to the option will vest on the first year anniversary measured from April 1, 2025 (the \"Vesting Commencement Date\") and one forty-eighth (1/48th) of the shares subject to the option will vest on each monthly anniversary of the Vesting Commencement Date thereafter, so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date."}],"balance_after":112350,"derivative":{"exercise_price":33.62,"expiration_date":"2035-03-31","underlying":"Common Stock","underlying_shares":37450},"source":{"system":"sec-edgar","filing":"0001610717-26-000137","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000161071726000137/form4.xml","form_type":"4"}},{"id":827150,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36687,"kind":"person","name":"Mancini Anthony","position":1,"cik":"0002124509","reported_name":"Mancini Anthony","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-03-27T00:04:12.000Z","date":"2026-03-25","kind":"sale","planned":true,"acquired":false,"shares":400,"price":97.2071,"value":38882.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Anthony Mancini on December 24, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"This transaction was executed in multiple trades at prices ranging from $97.12 to $97.34. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 54,400 Restricted Stock Units."}],"balance_after":54400,"source":{"system":"sec-edgar","filing":"0001610717-26-000137","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000161071726000137/form4.xml","form_type":"4"}},{"id":827149,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36687,"kind":"person","name":"Mancini Anthony","position":1,"cik":"0002124509","reported_name":"Mancini Anthony","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-03-27T00:04:12.000Z","date":"2026-03-25","kind":"sale","planned":true,"acquired":false,"shares":11036,"price":96.4299,"value":1064200.3764,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Anthony Mancini on December 24, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This transaction was executed in multiple trades at prices ranging from $96.00 to $96.99. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 54,400 Restricted Stock Units."}],"balance_after":54800,"source":{"system":"sec-edgar","filing":"0001610717-26-000137","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000161071726000137/form4.xml","form_type":"4"}},{"id":827148,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36687,"kind":"person","name":"Mancini Anthony","position":1,"cik":"0002124509","reported_name":"Mancini Anthony","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-03-27T00:04:12.000Z","date":"2026-03-25","kind":"sale","planned":true,"acquired":false,"shares":21086,"price":95.4859,"value":2013415.6874,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Anthony Mancini on December 24, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $95.00 to $95.99. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 54,400 Restricted Stock Units."}],"balance_after":65836,"source":{"system":"sec-edgar","filing":"0001610717-26-000137","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000161071726000137/form4.xml","form_type":"4"}},{"id":827147,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36687,"kind":"person","name":"Mancini Anthony","position":1,"cik":"0002124509","reported_name":"Mancini Anthony","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-03-27T00:04:12.000Z","date":"2026-03-25","kind":"sale","planned":true,"acquired":false,"shares":3128,"price":94.1561,"value":294520.2808,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Anthony Mancini on December 24, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $93.75 to $94.61. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 54,400 Restricted Stock Units."}],"balance_after":86922,"source":{"system":"sec-edgar","filing":"0001610717-26-000137","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000161071726000137/form4.xml","form_type":"4"}},{"id":827146,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36687,"kind":"person","name":"Mancini Anthony","position":1,"cik":"0002124509","reported_name":"Mancini Anthony","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-03-27T00:04:12.000Z","date":"2026-03-25","kind":"sale","planned":true,"acquired":false,"shares":1800,"price":93.223,"value":167801.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Anthony Mancini on December 24, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $92.69 to $93.65. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 54,400 Restricted Stock Units."}],"balance_after":90050,"source":{"system":"sec-edgar","filing":"0001610717-26-000137","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000161071726000137/form4.xml","form_type":"4"}},{"id":827145,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36687,"kind":"person","name":"Mancini Anthony","position":1,"cik":"0002124509","reported_name":"Mancini Anthony","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-03-27T00:04:12.000Z","date":"2026-03-25","kind":"exercise","planned":true,"acquired":true,"shares":37450,"price":33.62,"value":1259069.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Anthony Mancini on December 24, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 54,400 Restricted Stock Units."}],"balance_after":91850,"source":{"system":"sec-edgar","filing":"0001610717-26-000137","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000161071726000137/form4.xml","form_type":"4"}}]}